98%
921
2 minutes
20
Narrative medicine is defined as a medical approach that utilizes the power of stories, both patients' illness narratives and healthcare providers' reflective accounts, to promote healing, foster empathy, and enhance the therapeutic relationship through close attention to the language, metaphor, and meaning embedded in illness experiences. Despite its growing importance in contemporary healthcare, comprehensive bibliometric analyses of narrative medicine research trends remain limited. This study aims to systematically map global research patterns, identify key contributors, and analyze thematic evolution in narrative medicine literature over the past two decades. We conducted a comprehensive bibliometric analysis using the Citexs platform to examine narrative medicine research published from 2004 to 2024. The PubMed database was systematically searched using Boolean search terms: "narrative medicine OR medical storytelling OR clinical narrative OR patient-centered narrative OR healthcare narrative OR personalized medicine narrative". Inclusion criteria encompassed English-language articles only. Publication trends, geographic distribution, institutional productivity, author contributions, and thematic analysis were evaluated using advanced bibliometric techniques and the BioBERT biomedical language representation model for disease entity analysis. A total of 28,029 English-language articles were identified, demonstrating exponential growth with a peak output of 5,063 articles in 2024. The United States led global research productivity with 7,933 articles (28.3%), followed by the United Kingdom (4,704 articles, 16.78%) and Italy (2,743 articles, 9.79%). The University of Toronto emerged as the most productive institution (432 publications). Keyword analysis revealed "systematic review", "COVID-19", "treatment", and "artificial intelligence" as the most frequent terms, indicating the field's responsiveness to contemporary healthcare challenges and technological integration. Disease entity analysis identified "Neoplasms" (5,282 articles), "Death" (4,948 articles), "Pain" (4,345 articles), "Inflammation" (4,338 articles), and "Depressive Disorder" (3,933 articles) as the most commonly studied conditions. This bibliometric analysis demonstrates narrative medicine's transformation from a niche concept to a mainstream healthcare approach with substantial academic recognition. The exponential publication growth reflects increasing institutional support and clinical integration of narrative approaches. Geographic concentration in developed healthcare systems suggests opportunities for global expansion, particularly in culturally diverse contexts. The emergence of artificial intelligence as a research hotspot indicates the field's adaptive capacity to incorporate technological advances while maintaining humanistic principles. The predominance of cancer, death, pain, and mental health conditions underscores narrative medicine's particular relevance in addressing complex psychosocial dimensions of patient care that traditional biomedical approaches cannot fully capture. These findings emphasize narrative medicine's critical role in humanizing modern medical practice and its essential contribution to patient-centered care delivery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399044 | PMC |
http://dx.doi.org/10.7759/cureus.89211 | DOI Listing |
J Glob Antimicrob Resist
September 2025
Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Centre Rotterdam (Erasmus MC), Rotterdam, the Netherlands.
Osteoarthritis Cartilage
September 2025
Clinical Epidemiology Unit, Orthopaedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Electronic address:
Aim: To summarise key epidemiological and therapeutic research on osteoarthritis (OA) published between April 2024 and March 2025.
Methods: A narrative review was conducted using the MEDLINE database, focusing on English-language studies involving human participants published between April 1, 2024 and March 31, 2025. Eligible studies included observational longitudinal studies, systematic reviews, meta-analyses, and phase II-IV randomised controlled trials (RCTs) examining OA treatment and epidemiology.
Surv Ophthalmol
September 2025
Department of Surgery, Division of Ophthalmology, McMaster University, Hamilton, Ontario, Canada; Singapore Eye Research Institute, Singapore National Eye Center, Singapore. Electronic address:
This systematic review examines the prognostic value of baseline optical coherence tomography (OCT) biomarkers in predicting visual acuity (VA) outcomes for eyes with macular edema secondary to retinal vein occlusions (RVO) treated with anti-VEGF therapies, steroids, laser photocoagulation, or combination treatments. VA predictions at 6, 12, and 24 months post-treatment were assessed using a narrative synthesis approach and vote counting based on effect direction relative to a minimal clinically important difference. Certainty of evidence was evaluated using GRADE guidelines.
View Article and Find Full Text PDFAcad Pediatr
September 2025
Department of Pediatrics, University of Minnesota, Minneapolis, MN.
Safe and stable housing is foundational for child and adolescent health; likewise, housing instability and homelessness are associated with significant pediatric health risk. This narrative review sought to: (1) describe the impact of stable housing, housing instability, and homelessness on child and adolescent health, and (2) explore advocacy interventions for pediatricians to support unstably housed children, youth and families. While the relationship between health and housing is complex, here, we describe three primary mechanisms through which housing impacts pediatric health.
View Article and Find Full Text PDFNeurosci Biobehav Rev
September 2025
Murdoch Children's Research Institute, Melbourne, Australia; Department of Pediatrics, University of Melbourne, Melbourne, Australia.
This systematic review was conducted to provide a comprehensive summary of biopsychosocial factors associated with attention-deficit/hyperactivity disorder (ADHD) in children and adolescents with Neurofibromatosis Type 1 (NF1), and identify key limitations and gaps in the current literature. Systematic literature searches were conducted in Scopus, PsycINFO, Web of Science, PubMed, and ProQuest Dissertations and Theses Global in March 2024. The searches identified 2,345 unique articles.
View Article and Find Full Text PDF